ReviewOncoimmunology2020
Trial watch: TLR3 agonists in cancer therapy.
Julie Le Naour et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
75 papers cite itlatest 60 shown
this paperpooled itcites it
ReviewOncoimmunology2020
Julie Le Naour et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.